Sidebar Ads

Sunday, January 6, 2019

Why the Bristol-Myers Squibb Acquisition Is a Bad Deal for Celgene


Why the Bristol-Myers Squibb Acquisition Is a Bad Deal for Celgene



If this proposed acquisition was a game show, it would be called "The Price Isn't Right."

Related Posts:

0 comments:

Post a Comment

'I feel sick at the prospect of welfare cuts'

People on long-term sickness and disability benefits have told the BBC they fear how cuts will affect them. from BBC News https://ift.tt/2...